Cytomegalovirus infection after liver transplantation: Current concepts and challenges

Table 2 Estimated incidence of CMV disease during the first 12 mo after liver transplantation

	Use of anti-CMV prophylaxis
	Yes1	No
CMV D+/R-	12%-30%	44%-65%
CMV D+/R+	2.7%	18.2%
CMV D-/R+	3.9%	7.9%
CMV D-/R-	0	0
All patients	4.8%	18%-29%

D: Donor; R: Recipient.

¹Most cases occur as delayed-onset CMV disease. CMV disease occurs rarely during prophylaxis with oral valganciclovir. Data adapted from[4,5,73].